Cintirorgon

CAS No. 2055536-64-4

Cintirorgon( LYC-55716 )

Catalog No. M23919 CAS No. 2055536-64-4

Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 186 In Stock
25MG 312 In Stock
50MG 464 In Stock
100MG 672 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cintirorgon
  • Note
    Research use only, not for human use.
  • Brief Description
    Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
  • Description
    Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LYC-55716
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    RORγ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2055536-64-4
  • Formula Weight
    603.53
  • Molecular Formula
    C27H23F6NO6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:110 mg/mL (182.26 mM)
  • SMILES
    CC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lycera Announces Initiation of Phase 1/2a Study ARGON of Immuno-Oncology Candidate LYC-55716 in Patients with Advanced Solid Tumors. Jan 04, 2017.
molnova catalog
related products
  • Orexin 2 Receptor Ag...

    Orexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.

  • NSC 409012

    NSC 409012 is an active compound.

  • Ripasudil free base

    Ripasudil free base is a selective and potent ROCK inhibitor is a novel and potent antiglaucoma agent.